PSYC (PSYC) EBITDA Margin % : -696.97% (As of Sep. 2023)

View and export this data going back to 2007. Start your Free Trial

What is PSYC EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. PSYC's EBITDA for the three months ended in Sep. 2023 was $-0.23 Mil. PSYC's Revenue for the three months ended in Sep. 2023 was $0.03 Mil. Therefore, PSYC's EBITDA margin for the quarter that ended in Sep. 2023 was -696.97%.

PSYC EBITDA Margin % Historical Data

The historical data trend for PSYC's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PSYC EBITDA Margin % Chart

PSYC Annual Data

Trend

Dec11

Dec12

Dec13

Dec14

Dec16

EBITDA Margin %

-696.72

-380.95

-2,793.38

-1,141.76

PSYC Quarterly Data
	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Dec14	Mar15	Jun15	Sep15	Mar16	Jun16	Sep16	Dec16	Jun17	Sep22	Sep23
EBITDA Margin %	Get a 7-Day Free Trial															-	-	-216.39	48.28	-696.97

Competitive Comparison of PSYC's EBITDA Margin %

For the Advertising Agencies subindustry, PSYC's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PSYC's EBITDA Margin % Distribution in the Media - Diversified Industry

For the Media - Diversified industry and Communication Services sector, PSYC's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where PSYC's EBITDA Margin % falls into.

PSYC EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

PSYC's EBITDA Margin % for the fiscal year that ended in Dec. 2016 is calculated as

EBITDA Margin %	=	EBITDA (A: Dec. 2016 )	/	Revenue (A: Dec. 2016 )
	=	-2.253	/	0
	=	%

PSYC's EBITDA Margin % for the quarter that ended in Sep. 2023 is calculated as

EBITDA Margin %	=	EBITDA (Q: Sep. 2023 )	/	Revenue (Q: Sep. 2023 )
	=	-0.23	/	0.033
	=	-696.97 %

PSYC (OTCPK:PSYC) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

PSYC EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of PSYC's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

PSYC (PSYC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Communication Services » Media - Diversified » PSYC Corp (OTCPK:PSYC) » Definitions » EBITDA Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

2881 South Valley View Boulevard, Suite 9, Las Vegas, NV, USA, 89102

Website

https://www.psyccorporation.com

PSYC Corp is a media-focused company serving the expanding industry and community of medicinal psychedelics. Through its media platform, Psychedelic Spotlight, the company has positioned itself right at the very core of the psychedelics renaissance. Technical420 is also one such platform that provides information and analysis on public and private companies. These platforms provide the Company with an opportunity to dominate the intersection of cannabis and psychedelics as a media leader. Along with its subsidiary, the group offers public relations and media-focused services to companies within the medicinal psychedelics industry and other niche industries that includes cannabis, health, and wellness, and sports, among others.